India to Have Its First COVID-19 Vaccine by 2021, Announces Union Health Ministry
THD NewsDesk, NEW DELHI: On 13th September, the Union Health Minister Dr Harsh Vardhan announced on 'Sunday Samwaad' that soon...
Latest Post
Prescription No Longer a Prerequisite for Getting Tested, Says Kejriwal
THD NewsDesk, NEW DELHI: Delhi CM Arvind Kejriwal announced over Twitter that a doctor's prescription is no longer required to...
Phase-I Trial of China’s Only Nasal Spray Vaccine to Commence Shortly
THD NewsDesk, BEIJING: China has reportedly approved the clinical trial of its first nasal spray vaccine against the coronavirus on...
Patients Can’t Be Denied Services by Private Hospitals, Says Bombay HC
THD NewsDesk, NAGPUR: On 10th September, the Bombay High Court ruled that patients can not be refused admission in private...
Newly Discovered Gene could reduce chances of Alcoholic Cirrhosis, claims Study
THD NewsDesk, INDIANA (USA): A team of researchers at Indiana University School of Medicine is dedicatedly working on a study...
Lilly Claims its Antibody Drug Can Bring Down COVID-19 Hospitalization Rate
THD NewsDesk, INDIANA (USA): Eli Lilly and Co. proudly announced that it has masterfully developed an experimental antibody treatment that could...
Kerala Gets Its First COVID Dedicated Hospital
THD NewsDesk, THIRUVANANTPURAM: India's first-ever dedicated Covid-19 hospitals since the pandemic began was inaugurated in Kerala's Kasargod by CM Pinarayi...
Infosys All Set to Acquire Kaleidoscope Communication for $42 Million
THD NewsDesk, BENGALURU: Global Software major Infosys has reportedly bought US-based Kaleidoscope Communication for $42 mn. Kaleidoscope is a product...
ICMR Trial Results Advocate Against the Use of Plasma Therapy
THD NewsDesk, NEW DELHI: The Indian Council of Medical Research (ICMR) on 15th September, cautioned on the future use of...
ICMR Study Proves Plasma Therapy Ineffective in Curtailing COVID Mortality Rate
THD NewsDesk, NEW DELHI: A recent ICMR study indicates that administering convalescent plasma to coronavirus patients is negligibly effective in...
